Doctor Scott M. Rocklage, PhD has been working for the 5AM Ventures in the capacity of managing partner from the year 2004 after joining the 5 AM Ventures in the year 2003 in the capacity of a venture partner.
5AM Ventures has offices at Carlifornia, San Fransisco and Waltham (where Dr. Rocklage is based). Doctor Rocklage attended the University of California for his bachelors degree in chemistry.
He later furthered his studies in the chemistry field at the Massachusetts Institute of Technology (MIT) and acquired a Doctor of Philosophy (PhD) in Chemistry with assistance from the year 2005 chemistry Nobel Prize winner Richard R. Schrock. He conducted his doctorate researches at the Laboratory of Richard R. Schrock. Read more: Scott Rocklage | LinkedIn and Scott Racklage | Bloomberg
Doctor Scott Rocklage has made a number of inventions in chemistry both individually and with assistance from fellow scholars in chemistry and has been featured on more than 30 patents in the United States. The doctor has also helped more than 100 individuals through making reviews of their publications.
Doctor Scott Rocklage has served in a number of senior management positions in his career. He was a Chief Executive Officer and Chairman of Board at the Cubist Pharmaceuticals, Chief Executive Officer and President at the Nycomed Salutar and Chairman of the Board at Relypsa and Novira. Learn more about Scott Rocklage: https://thebrotalk.com/bro-bio/bro-bio-enigmatic-mysterious-life-dr-scott-rocklage/
The doctor also served in the capacity of an Executive Chairman at Miikana, Illypsa, Semprus and Extreemed Companies as well as serving in the research and development capacities at Salutar and Catalytica Companies.
Doctor Sott Rocklage is currently previledged to serve in a number of Boards as the Chairman among them Kinestral and Cidara, Rennovia and Epirus and Pulmatrix.
All these responsibilities has seen doctor Scott Rocklage stay in the chemistry field for more than 30 years. All this experience has made him a Food and Drug Administration approval of three New Drug Applications located in the United States which are the Cubicin ®, the Teslscan ® and the Omniscan™. Doctor Scott Rocklage also takes part in the search for new drugs and he has made a number of clinical tests for his new drugs.